n/a
Article Publish Status: FREE
Abstract Title:

Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models.

Abstract Source:

Mol Med Rep. 2021 Jan ;23(1):1. Epub 2020 Nov 12. PMID: 33179093

Abstract Author(s):

Lianli He, Xiaojuan Wang, Daigang Cheng, Zhengai Xiong, Xiaoyun Liu

Article Affiliation:

Lianli He

Abstract:

The aim of the present study was to investigate the effects of the ginsenoside Rg1 on D‑galactose (D‑gal)‑induced mouse models of premature ovarian insufficiency (POI) and the related mechanisms. C57BL/6 female mice were randomly grouped into the following: i) D‑gal [subcutaneously (s.c.) 200 mg/kg/d D‑gal for 42 days]; ii) Rg1 [intraperitoneally (i.p.) 20 mg/kg/d Rg1for 28 days]; iii) D‑gal + Rg1 (s.c. 200 mg/kg/d D‑gal for 42 days followed by i.p. 20 mg/kg/d Rg1 for 28 days); and iv) saline groups (equivalent volume of saline s.c. and i.p.). Hematoxylin and eosin staining and electron microscopy were used to analyze uterine and ovarian morphology. Expression levels of senescence factors (p21, p53 and serine/threonine kinase), secretion of pro‑inflammatory cytokines [interleukin (IL)‑6, tumor necrosis factor (TNF)‑α and IL‑1β] and the activities of oxidation biomarkers [superoxide dismutase (T‑SOD), malondialdehyde (MDA) and glutathione peroxidase (GSH‑px)] were analyzed. The results showed that mice in the Rg1 + D‑gal group had significantly higher uterine and ovarian weight compared with those in the D‑gal group. Uterus morphology was also improved, based on the comparison between the D‑gal group and the Rg1 + D‑gal group. In addition, the Rg1 treatment after D‑gal administration significantly decreased the expression of senescence‑associated factors, enhanced the activities of anti‑oxidant enzymes total T‑SOD and GSH‑px in addition to reducing TNF‑α, IL‑1β, MDA and IL‑6 (based on the comparison between the D‑gal group and the Rg1 + D‑gal group). In conclusion, the present study suggested that the ginsenoside Rg1 improved pathological damages in the ovary and uterus by increasing anti‑oxidant and anti‑inflammatory abilities whilst reducing the expression of senescence signaling pathways in POI mouse models.

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.